MyHealthChecked (LON:MHC) Stock Price Down 4.1% – Time to Sell?
by Mitch Edgeman · The Markets DailyShares of MyHealthChecked PLC (LON:MHC – Get Free Report) dropped 4.1% during trading on Tuesday . The company traded as low as GBX 12 ($0.16) and last traded at GBX 12.23 ($0.16). Approximately 8,414 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 100,335 shares. The stock had previously closed at GBX 12.75 ($0.17).
MyHealthChecked Stock Performance
The stock has a 50-day moving average of GBX 12.65 and a 200 day moving average of GBX 11.07. The stock has a market capitalization of £6.50 million, a price-to-earnings ratio of -600.00 and a beta of 1.37. The company has a debt-to-equity ratio of 0.16, a current ratio of 12.22 and a quick ratio of 2.00.
About MyHealthChecked
MyHealthChecked PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. It offers general health and energy profile blood test, bowel health rapid test, and stomach ulcer rapid test; nutritional health tests, such as intolerances and sensitivities DNA tests, vitamins and minerals DNA and profile blood tests, iron deficiency rapid test, and vitamin D rapid test; and weight management tests, that includes weight management DNA and blood tests, glucose management DNA tests, thyroid profile blood test, and stimulating hormone rapid test.
Further Reading
- Five stocks we like better than MyHealthChecked
- Ride Out The Recession With These Dividend Kings
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- There Are Different Types of Stock To Invest In
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?